---
title: Challenges and breakthroughs in drug discovery
videoId: xlMTWfkQqbY
---

From: [[lexfridman]] <br/> 

Drug discovery has long been a complex field, filled with both opportunities and hurdles. Daphne Koller, a professor of computer science and a prominent figure in the intersection of [[the_role_of_artificial_intelligence_in_drug_discovery | artificial intelligence and drug discovery]], provides insights into the ongoing challenges and breakthroughs in this critical area, informed by her experiences leading Inceptro, a company at the forefront of these innovations.

## Challenges in Drug Discovery

### Complexity of Disease Mechanisms

One of the core challenges in drug discovery is the intricate nature of disease mechanisms. Many diseases, such as Alzheimer's, schizophrenia, and type 2 diabetes, have complex and poorly understood underlying causes, which makes discovering effective treatments difficult <a class="yt-timestamp" data-t="04:01">[04:01]</a>. For instance, Alzheimer's disease remains "closer to zero" in our understanding due to unvalidated hypotheses about its causes <a class="yt-timestamp" data-t="05:01">[05:01]</a>.

### Limitations of Animal Models

Traditional animal models often fail to accurately represent human disease mechanisms. Diseases like Alzheimer's and diabetes do not occur naturally in animals like mice, leading to significant discrepancies when translating findings from animal models to human conditions <a class="yt-timestamp" data-t="17:00">[17:00]</a>.

### Genetic Variability and Lack of Data

The genetic variability among humans adds another layer of complexity. While induced pluripotent stem (iPS) cells provide a scalable way to study diseases at the cellular level, there's still a limited number of iPS cells available, counted in thousands rather than millions. This hinders the ability to capture the complete genetic landscape necessary for effective drug discovery <a class="yt-timestamp" data-t="22:07">[22:07]</a>.

## Breakthroughs and Innovations

### Disease-in-a-Dish Models

A significant breakthrough in drug discovery is the development of "disease-in-a-dish" models. Enabled by technologies like iPS cells and CRISPR gene editing, researchers can now create human cells with specific genetic mutations to better study disease mechanisms. This method allows for more accurate modeling of human diseases in vitro, offering a pathway to discovering treatments that are more likely to be effective in humans <a class="yt-timestamp" data-t="20:19">[20:19]</a>.

### Machine Learning and Data Analytics

Machine learning is playing an increasingly pivotal role in understanding diseases. By generating large, high-quality datasets, researchers can apply machine learning to build predictive models that identify cellular patterns associated with diseases, potentially uncovering new drug targets and interventions <a class="yt-timestamp" data-t="11:00">[11:00]</a>.

### Advancements in Biotechnology and Analytics

Advances in biotechnology, such as super-resolution microscopy and single-cell RNA sequencing, have enhanced our ability to quantify cellular processes at unprecedented resolutions <a class="yt-timestamp" data-t="28:29">[28:29]</a>. These technologies are crucial for generating the detailed datasets required for effective application of machine learning in drug discovery <a class="yt-timestamp" data-t="28:34">[28:34]</a>.

## Conclusion

Despite the challenges, the field of drug discovery is experiencing a wave of innovation, powered by new technologies and data-driven approaches. As researchers continue to navigate the complexities of diseases and experiment with novel models, breakthroughs in [[challenges_and_advancements_in_cancer_treatments | treatments for major diseases]] may become increasingly feasible. The ongoing integration of [[machine_learnings_impact_on_drug_discovery_and_development | machine learning]] and data analytics in this field holds promise for accelerating the pace at which we can discover and develop effective therapeutics.